| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
TytoCare The remote examination company is shifting focus from low-acuity primary care toward cardiopulmonary and oncology support | Series C Published on thinner evidence, 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date. | $25M | 2018-01-29 | [ LEAD ] |